Dani Bancroft, Author at Labiotech.eu

morphosys genmab janssen cancer immunotherapy

News and Trends 28 Jan 2019

Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents

Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after the US District Court of Delaware declared three of its cancer immunotherapy patents invalid. MorphoSys began…

January 28, 2019 - 3 minutesmins - By Dani Bancroft

News and Trends 19 Nov 2016

Looking for outperforming cell lines ? CHOvolution is an all-in-one kit for GMP Bioproduction

For any drug developer or service provider, cell line development is one of the most challenging phases, especially when subsequent GMP compliance is required. The need to secure good cell lines can, therefore, make…

November 19, 2016 - 4 minutesmins - By Dani Bancroft

Sanofi regeneron rheumatoid arthritis salurimab

News and Trends 31 Oct 2016

UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug

Sanofi and Regeneron (NY, US) have ruled their phase III clinical trial immunotherapy Sarilumab a huge success. Now awaiting US FDA and EMA approval, the results from the latest study…

October 31, 2016 - 3 minutesmins - By Dani Bancroft

medimmune astrazeneca cancer pd l1 nsclc trial pd l1

News and Trends 28 Oct 2016

UPDATE: Immuno-Oncology Combo works on Lung Cancer Regardless of PD-L1 Type

AstraZeneca's MedImmune (UK) has published phase Ib study results in The Lancet Oncology. These showed anti-tumour activity of a combination of investigational antibodies in patients with lung cancer. The trial considered patients undergoing treatment…

October 28, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 29 Jul 2016

Polish Selvita’s Inflammation Research used to start new Biotech in Scotland

The new Biotech Nodthera will be based in Edinburgh and focus on the discovery and development of novel small molecule candidates to treat inflammation in a range of autoimmune diseases. Founded by…

July 29, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 28 Jul 2016

World Hepatitis Day 2016: What is the plan for Biotech and Policy Makers?

What is the purpose of the #NoHep campaign? To get rid of the inflammatory Liver viruses which are responsible for killing up to 1.4 million people each year, by 2030. …

July 28, 2016 - 2 minutesmins - By Dani Bancroft

biobased economy eu greentech ibbess interview biotechnology electricity plant green startup barcelona

News and Trends 26 Jul 2016

Be part of the European BioEconomy! Here are 3 Dutch GreenTech Events this Year

Here are 3 events to kickstart your greentech career. As Europe works towards a bioeconomy, challenges like these offer the opportunity to get involved and make Green ideas come to life. Put…

July 26, 2016 - 4 minutesmins - By Dani Bancroft

why lithuania biotech baltic life sciences

News and Trends 26 Jul 2016

What is Lithuania’s role in European Biotech?

Since the days of the Soviet Union, Lithuania has always been considered as a leader in life sciences discoveries in Eastern Europe due to its infrastructure. But what about for Biotech?…

July 26, 2016 - 2 minutesmins - By Dani Bancroft

micreos eczema mrsa infection dermatitis antibiotic biotech

News and Trends 25 Jul 2016

Eczema could also be caused by Superbugs, so how could this Biotech fight it?

A new study has shown that on average, 70% of eczema patients are colonised with Staphylococcus aureus bacteria on their skin lesions (which include MRSA). Could this the Dutch biotech Micreos therefore have the…

July 25, 2016 - 3 minutesmins - By Dani Bancroft

inflarx inflammation fundraising itx 1 biotech antibody

News and Trends 22 Jul 2016

German Biotech raises extra €31M to get first-in-class Antibody through trials

InflaRx, a German-based biopharma, has raised €31M in a series C fundraising. This is to further advance a potentially first-in-class antibody which targets an acute form of self-inflammation. Based in Jena, InflaRx’s…

July 22, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 18 Jul 2016

Switzerland discovers Pomegranate ‘Anti-Ageing’ Effect and founds Biotech

Researchers at the École Polytechnique Fédérale de Lausanne (EPFL) have uncovered a molecule in the pomegranate fruit which can prolong the lifespan of animal models. The co-authors who published in Nature went to co-found a…

July 18, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 15 Jul 2016

UK Biotech buys Swiss Antibodies to accelerate CAR-T Development

Cell Medica is a London-based biotech which develops, manufactures and markets personalised cell immunotherapeutics for infectious disease and cancer. It has therefore just acquired a Swiss antibody manufacturing biotech Delenex, to help its…

July 15, 2016 - 3 minutesmins - By Dani Bancroft

biotech infographic personalised edicine genetic disease

News and Trends 15 Jul 2016

Infographic: What are the key challenges in Personalized Medicine?

Personalized medicine is the way forward in tackling hard-to-treat indications. Here are some of the challenges in R&D of such therapies in biotech. By exploring use of autologous therapies, the…

July 15, 2016 - 1 minutemin - By Dani Bancroft

News and Trends 14 Jul 2016

Institut Pasteur & Austrian Biotech also join the World Zika Vaccine Plan

Themis is a Vienna-based vaccine developer. Together with the Institut Pasteur, it is now planning to use a measles vaccine construct to develop and start Zika vaccine trials within the next 12 months. Themis has successfully…

July 14, 2016 - 3 minutesmins - By Dani Bancroft

oxitec brazil mosquito gmo vector control zika dengue malaria city

News and Trends 14 Jul 2016

UPDATE: Brazilian city to be first in World to deploy GM Mosquitos against Dengue Fever

Oxitec's genetically engineered Mosquito trial is being expanded in Brazil's Piracicaba region, to cover a city of over 60,000 people. With support from Ministry officials and the WHO, this UK…

July 14, 2016 - 4 minutesmins - By Dani Bancroft

pharnext marie tooth disease IPO pharnext

News and Trends 14 Jul 2016

French Biotech that makes Drugs faster and cheaper IPO’s for €31M

Pharnext has successfully completed its IPO on the Euronext Paris exchange, allowing it to move forward with Phase II and III trials for Neurological diseases that include Alzheimer's. Based in…

July 14, 2016 - 2 minutesmins - By Dani Bancroft

servier sorrento pd 1 biotech chemo car t cancer

News and Trends 13 Jul 2016

French Pharma licenses California PD-1 Cancer Antibody for €710M

San Diego's Sorrento Therapeutics has bagged a quarter-billion euro deal with Servier. The French Pharma giant will develop Sorrento's PD-1 targeting platform - a key checkpoint inhibitor in Immuno-Oncology. Sorrento's proprietary G-MAB…

July 13, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 13 Jul 2016

Europe’s most valuable Biotech just launched 2 new Trials

Within a week, Actelion has announced both Phase II and III trial studies for insomnia and hypertension in children. Even for Europe's most valuable biotech, this is an impressive period.…

July 13, 2016 - 3 minutesmins - By Dani Bancroft

ono pharmaceutical biotech celyad cancer nk cell therapy

News and Trends 12 Jul 2016

Unique Natural Killer T-Cell Therapy secures €282M in Japan Deal

Belgian Celyad granted an exclusive license to Osaka based ONO Pharmaceutical for the development and commercialisation of Celyad’s unique allogeneic cell therapy in Japan, Korea and Taiwan. This license agreement opens new…

July 12, 2016 - 3 minutesmins - By Dani Bancroft

HIV diagnostic helen lee epo biotech inventor europe samba

News and Trends 12 Jul 2016

How did Helen Lee overcome barriers to HIV Diagnostics in the ‘Real World’?

How can diagnostics be improved in resource limited settings? And how can the practical limitations of transporting heat-sensitive assay material through hot climates be overcome? The University of Cambridge's Dr Helen…

July 12, 2016 - 6 minutesmins - By Dani Bancroft

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

About

Articles by Dani Bancroft

Outsourcing in life science R&D today

Are you out-licensing?

Subscribe to our newsletter to get the latest biotech news!